Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The penicillins.

A J Wright1

  • 1Division of Infectious Diseases and Internal Medicine, Mayo Clinic Rochester, Minnesota 55905, USA.

Mayo Clinic Proceedings
|March 25, 1999
PubMed
Summary
This summary is machine-generated.

Penicillin antibiotics have evolved significantly, from early penicillin G to advanced combinations with beta-lactamase inhibitors, expanding their effectiveness against resistant bacteria.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extraction of optical properties from scattering media using a convolutional neural network and diverse exit information.

Optics letters·2025
Same author

Simulating atmospheric drought: Silica gel packets dehumidify mesocosm microclimates.

Ecology and evolution·2024
Same author

Atmospheric drying and soil drying: Differential effects on grass community composition.

Global change biology·2024
Same author

Simulating atmospheric drought: Silica gel packets dehumidify mesocosm microclimates.

bioRxiv : the preprint server for biology·2023
Same author

Comparison of static and dynamic <i>in vitro</i> digestibility and bioaccessibility of palm-based emulsions and correlation to a human study: effects of triacylglycerol crystallinity.

Food & function·2023
Same author

C-terminal citrullinated peptide alters antigen-specific APC:T cell interactions leading to breach of immune tolerance.

Journal of autoimmunity·2023
Same journal

37-Year-Old Woman With Jaundice.

Mayo Clinic proceedings·2026
Same journal

34-Year-Old Woman With An Unidentified Overdose.

Mayo Clinic proceedings·2026
Same journal

Use of Bronchoscopic Cryobiopsy in Evaluating Interstitial Lung Disease: Radiologic Predictors of Diagnostic Yield and Safety.

Mayo Clinic proceedings·2026
Same journal

Advancing Pulmonary Fibrosis Care: Integrating Genomic Insights Into Clinical Practice.

Mayo Clinic proceedings·2026
Same journal

RAAS Inhibition in the ICU: Stop, Continue, or Restart?

Mayo Clinic proceedings·2026
Same journal

Chronic Kidney Disease-In the Limelight, July 2026.

Mayo Clinic proceedings·2026
See all related articles

Area of Science:

  • Pharmacology
  • Microbiology
  • Medicinal Chemistry

Background:

  • Penicillin antibiotics are crucial for treating bacterial infections due to their bactericidal activity, body distribution, low toxicity, and efficacy.
  • The development of penicillins has progressed from penicillin G to address specific bacterial resistance and expand antimicrobial spectrum.
  • Key advancements include penicillinase-resistant penicillins, aminopenicillins for Gram-negative activity, and extended-spectrum agents like carboxypenicillins and ureidopenicillins.

Purpose of the Study:

  • To provide a historical overview of the evolution of penicillin antibiotics.
  • To highlight the development of various penicillin classes in response to bacterial resistance and the need for broader antimicrobial activity.
  • To discuss the role of beta-lactamase inhibitors in enhancing penicillin efficacy against resistant bacteria.

Related Experiment Videos

Main Methods:

  • Literature review of penicillin development and applications.
  • Analysis of the chemical modifications and resulting antimicrobial spectra of different penicillin classes.
  • Examination of the impact of beta-lactamase inhibitors on penicillin effectiveness.

Main Results:

  • Penicillin G was effective against streptococcal and staphylococcal infections.
  • Penicillinase-resistant penicillins (e.g., methicillin) were developed against Staphylococcus aureus.
  • Aminopenicillins broadened activity to include Gram-negative bacteria like E. coli.
  • Carboxypenicillins and ureidopenicillins further extended spectra to include Pseudomonas aeruginosa.
  • Combinations with beta-lactamase inhibitors (e.g., clavulanic acid) overcome resistance from certain beta-lactamases.

Conclusions:

  • The penicillin class has undergone continuous development to combat bacterial resistance and broaden antimicrobial efficacy.
  • Combinations of penicillins with beta-lactamase inhibitors represent a significant advancement in treating resistant bacterial infections.
  • The ongoing goal is to develop an ideal penicillin with enhanced bactericidal activity, bioavailability, and resistance to bacterial defense mechanisms.